LAHORE, JULY 2018:CCL’s Management Trainee Program was recently launched and shortlisting of candidates is underway to find future leaders who may be at the helm of CCL affairs in years to come. “We arequite happy at the rousing response received from some of the leading universities in Pakistan. We believe that as part of our ...

LAHORE, JULY 2018: CCL Pharmaceuticals recently launched the first ever ticagrelor in Pakistan in a ceremony held in a local hotel in Lahore. Ticagrelor is an FDA approved antiplatelet therapy to reduce blood clot formation, which significantly reduces cardiovascular events and deaths in heart attack survivors. Cardiac patients receiving antiplatelet therapy have a new option with the launch ...